Sobrevida a cinco años en pacientes con cáncer de ovario epitelial avanzado sometidas a cirugía de Citorreducción óptima en el Hospital Teodoro Maldonado Carbo durante 2015 - 2019.

Abstract

Introduction: Epithelial ovarian cancer is a malignant pathology that affects women between 50 and 70 years of age with the highest incidence, occupying the fifth cause of gynecological death in the world. One of the treatments with high survival is optimal debulking surgery, the objective of which is to resect the macroscopic tumor. Objective: To determine the survival of advanced epithelial ovarian cancer stages IIIC and IV in percentage at 5 years, treated with optimal debulking surgery in the area of gynecology of Hospital de Especialidades Teodoro Maldonado Carbo from 2015 to 2019. Methodology: Longitudinal study, Observational and retrospective in 82 patients with epithelial ovarian cancer in advanced stages. Statistics carried out with the IBM SPSS Statistics 22.0 program. Results: Women between the ages of 30 to 65 years show a 45% 5-year survival of epithelial ovarian cancer after optimal cytoreductive surgery, and present a relative survival of the stages with tumor progression, that is, stage IIIC shows greater survival (73%) compared to stages IVA and IVB, with survivals of 30% and 0%, respectively. The factors that affect survival in the investigated patients are the values of the tumor marker CA-125, the histological type of the tumor and, consequently, age. Conclusions: The 5-year survival of advanced epithelial ovarian cancer is 45% with the primary surgical treatment. This study also concludes the benefit of surgery with the quantification of CA-125 in post-surgical controls.